Add BrightSurf on Google Email

Double strike against tuberculosis

Researchers at TUM and Harvard University discovered a substance that interferes with the formation of Mycobacterium tuberculosis' mycomembrane. Combining this beta-lactone inhibitor with known antibiotics increases effectiveness by up to 100-fold, making it a promising new therapy for TB.

SourceTechnical University of Munich (TUM)·JournalAngewandte Chemie International Edition·DateDec 28, 2017

Bacteria acquire resistance from competitors

Researchers have discovered that bacteria can inject toxic proteins into their competitors, causing cell lysis and death, and then acquire antibiotic resistance by incorporating the released genetic material. This ability allows bacteria to rapidly develop resistance to antibiotics, posing a significant threat to patients in hospitals.

SourceUniversity of Basel·JournalCell Reports·DateDec 27, 2017

The body's street sweepers

A new study reveals that platelets actively migrate to sites of infection, collecting bacteria into aggregates and facilitating the activation of neutrophils. This active function has significant implications for our understanding of immune defense and potential therapeutic targets for inflammation reactions.

Going undercover to fight tuberculosis

Researchers have developed a new antibiotic, EZ120, that targets the mycomembrane biosynthesis of tuberculosis pathogen Mycobacterium tuberculosis. By inhibiting key enzymes, EZ120 significantly increases the effectiveness of conventional antibiotics, offering a novel approach for tuberculosis treatment.

SourceWiley·JournalAngewandte Chemie International Edition·DateDec 8, 2017

Bacteria activate their own killer

Researchers have developed a novel photothermal treatment that leverages the self-activation of certain bacteria to target and kill antibiotic-resistant pathogens. The innovative approach uses a supramolecular radical anion complex that absorbs near-infrared light, generating heat and denaturing proteins in targeted bacteria.

SourceWiley·JournalAngewandte Chemie International Edition·DateDec 7, 2017

When Listeria monocytogenes goes to sleep....

Researchers discovered Listeria monocytogenes can change its behavior when infecting liver and placenta cells, producing a dormant form that is more tolerant of antibiotics. This finding explains the long incubation period of listeriosis and may lead to new therapeutic strategies.

SourceInstitut Pasteur·JournalPLOS Pathogens·DateDec 1, 2017

Managing antibiotics not enough to reverse resistance

Researchers found that bacteria can quickly share genes to maintain resistance, making it unlikely that reducing antibiotic use will reverse the trend. However, conjugation rates can be disrupted and reversed using existing drugs, paving the way for future development of new treatments.

SourceDuke University·JournalNature Communications·DateNov 22, 2017

Model sheds new light on pathogen cooperation

A new model reveals that cooperative contagion processes can lead to more severe spread of infectious diseases, generating abrupt outbreak transitions and multi-stability. This discovery highlights the need for new containment strategies to combat epidemics in realistic systems.

SourceIOP Publishing·JournalNew Journal of Physics·DateNov 15, 2017

Microbial murder mystery solved

Killer cells use a methodical approach to destroy bacterial invaders, inflicting oxidative damage and targeting critical proteins with the deadly enzyme granzyme B. The discovery offers new insights into how immune systems combat bacteria, potentially leading to the development of new antimicrobial drugs.

SourceBoston Children's Hospital·JournalCell·DateNov 8, 2017

Revealed new target for development of antibiotics aimed at highly resistant bacteria

Researchers from Brazil and France identify a new target for developing antibiotics against highly resistant bacteria, inhibiting the interaction of two key proteins involved in cell wall elongation. The discovery paves the way for the development of antibiotics with a different action mechanism, offering hope in combating drug-resista...

Bacteria have a sense of touch

Researchers discovered bacteria possess a 'sense of touch' enabling them to recognize surfaces and induce adhesive production in response to mechanical stimulation. This mechanism helps pathogens colonize host cells, making it crucial for understanding infectious diseases.

SourceUniversity of Basel·JournalScience·DateOct 26, 2017

Gut bacterium indirectly causes symptoms by altering fruit fly microbiome

A new study found that CagA, a protein produced by the bacterium Helicobacter pylori, can alter the population of microbes living in the fruit fly gut, leading to disease symptoms. The researchers suggest that manipulating the balance of microbes in the gut may be able to mitigate the harmful effects of infection with H. pylori.

SourcePLOS·JournalPLOS Pathogens·DateOct 19, 2017